

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.49505403 |
| 2 | proteasome assembly (GO:0043248) | 5.42739046 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.38556342 |
| 4 | chaperone-mediated protein transport (GO:0072321) | 4.96382304 |
| 5 | ATP synthesis coupled proton transport (GO:0015986) | 4.82104132 |
| 6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.82104132 |
| 7 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.67281832 |
| 8 | respiratory electron transport chain (GO:0022904) | 4.41653628 |
| 9 | regulation of mitochondrial translation (GO:0070129) | 4.39127780 |
| 10 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.36330625 |
| 11 | electron transport chain (GO:0022900) | 4.32083422 |
| 12 | respiratory chain complex IV assembly (GO:0008535) | 4.12050788 |
| 13 | protein complex biogenesis (GO:0070271) | 4.11308916 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.06071962 |
| 15 | response to peptidoglycan (GO:0032494) | 3.99648659 |
| 16 | protein neddylation (GO:0045116) | 3.94212963 |
| 17 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.93319634 |
| 18 | pseudouridine synthesis (GO:0001522) | 3.93216816 |
| 19 | NADH dehydrogenase complex assembly (GO:0010257) | 3.90668433 |
| 20 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.90668433 |
| 21 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.90668433 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.89328020 |
| 23 | L-phenylalanine catabolic process (GO:0006559) | 3.89328020 |
| 24 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.84040097 |
| 25 | maturation of SSU-rRNA (GO:0030490) | 3.78824518 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.76584835 |
| 27 | L-phenylalanine metabolic process (GO:0006558) | 3.76584835 |
| 28 | protein targeting to mitochondrion (GO:0006626) | 3.76257683 |
| 29 | granulocyte activation (GO:0036230) | 3.76207583 |
| 30 | termination of RNA polymerase III transcription (GO:0006386) | 3.74131124 |
| 31 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.74131124 |
| 32 | cytochrome complex assembly (GO:0017004) | 3.72552189 |
| 33 | neutrophil activation (GO:0042119) | 3.69609482 |
| 34 | ribosomal small subunit biogenesis (GO:0042274) | 3.69361724 |
| 35 | regulation of activation of Janus kinase activity (GO:0010533) | 3.68719474 |
| 36 | rRNA modification (GO:0000154) | 3.67419767 |
| 37 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.66034709 |
| 38 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.65257151 |
| 39 | DNA deamination (GO:0045006) | 3.54110399 |
| 40 | central nervous system myelination (GO:0022010) | 3.50739202 |
| 41 | axon ensheathment in central nervous system (GO:0032291) | 3.50739202 |
| 42 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.47202876 |
| 43 | respiratory burst (GO:0045730) | 3.46346975 |
| 44 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.40925496 |
| 45 | ribosomal small subunit assembly (GO:0000028) | 3.40855260 |
| 46 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.38796695 |
| 47 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.38641959 |
| 48 | T-helper 1 type immune response (GO:0042088) | 3.36409655 |
| 49 | ribosomal large subunit biogenesis (GO:0042273) | 3.35800443 |
| 50 | establishment of protein localization to mitochondrion (GO:0072655) | 3.35419387 |
| 51 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.34668701 |
| 52 | negative regulation of ligase activity (GO:0051352) | 3.34668701 |
| 53 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.32368646 |
| 54 | protein localization to mitochondrion (GO:0070585) | 3.32189984 |
| 55 | positive regulation of antigen processing and presentation (GO:0002579) | 3.30312337 |
| 56 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.29551054 |
| 57 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.27724018 |
| 58 | glyoxylate metabolic process (GO:0046487) | 3.27274163 |
| 59 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.26789677 |
| 60 | defense response to protozoan (GO:0042832) | 3.26362411 |
| 61 | purine nucleobase biosynthetic process (GO:0009113) | 3.25898921 |
| 62 | eosinophil chemotaxis (GO:0048245) | 3.25448271 |
| 63 | cellular response to interferon-beta (GO:0035458) | 3.24720088 |
| 64 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.23554211 |
| 65 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.22480313 |
| 66 | CENP-A containing nucleosome assembly (GO:0034080) | 3.22124438 |
| 67 | chromatin remodeling at centromere (GO:0031055) | 3.21986063 |
| 68 | regulation of RIG-I signaling pathway (GO:0039535) | 3.19562799 |
| 69 | response to muramyl dipeptide (GO:0032495) | 3.18097001 |
| 70 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.17960094 |
| 71 | response to interferon-beta (GO:0035456) | 3.16995039 |
| 72 | translation (GO:0006412) | 3.16572197 |
| 73 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.15498258 |
| 74 | cellular response to exogenous dsRNA (GO:0071360) | 3.12838474 |
| 75 | cotranslational protein targeting to membrane (GO:0006613) | 3.10929517 |
| 76 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.09691577 |
| 77 | protein targeting to ER (GO:0045047) | 3.08505346 |
| 78 | purine nucleotide salvage (GO:0032261) | 3.07842104 |
| 79 | viral transcription (GO:0019083) | 3.07240249 |
| 80 | ribosome assembly (GO:0042255) | 3.07009074 |
| 81 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.06888381 |
| 82 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.06445161 |
| 83 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.06445161 |
| 84 | modulation by symbiont of host immune response (GO:0052553) | 3.06445161 |
| 85 | positive regulation by symbiont of host defense response (GO:0052509) | 3.06445161 |
| 86 | modulation by symbiont of host defense response (GO:0052031) | 3.06445161 |
| 87 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.06445161 |
| 88 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.05608620 |
| 89 | amyloid precursor protein catabolic process (GO:0042987) | 3.05440617 |
| 90 | cellular component biogenesis (GO:0044085) | 3.04678998 |
| 91 | rRNA processing (GO:0006364) | 3.04662838 |
| 92 | mitochondrial transport (GO:0006839) | 3.04337695 |
| 93 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.02536100 |
| 94 | aerobic respiration (GO:0009060) | 3.01222750 |
| 95 | myeloid cell activation involved in immune response (GO:0002275) | 3.00315100 |
| 96 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.99017256 |
| 97 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.99017256 |
| 98 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.99017256 |
| 99 | spliceosomal snRNP assembly (GO:0000387) | 2.98874857 |
| 100 | translational termination (GO:0006415) | 2.98406953 |
| 101 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.98387798 |
| 102 | oxidative phosphorylation (GO:0006119) | 2.98158967 |
| 103 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.97626186 |
| 104 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.97626186 |
| 105 | eosinophil migration (GO:0072677) | 2.97562281 |
| 106 | protein localization to endoplasmic reticulum (GO:0070972) | 2.96499991 |
| 107 | autophagic vacuole fusion (GO:0000046) | 2.96479783 |
| 108 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.95662858 |
| 109 | regulation of antigen processing and presentation (GO:0002577) | 2.95068218 |
| 110 | regulation of cellular amine metabolic process (GO:0033238) | 2.94808663 |
| 111 | cullin deneddylation (GO:0010388) | 2.93962848 |
| 112 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.93214822 |
| 113 | nucleobase biosynthetic process (GO:0046112) | 2.92736580 |
| 114 | rRNA metabolic process (GO:0016072) | 2.92654728 |
| 115 | microglial cell activation (GO:0001774) | 2.91448320 |
| 116 | positive regulation of interferon-alpha production (GO:0032727) | 2.91088063 |
| 117 | positive regulation of interleukin-17 production (GO:0032740) | 2.90873511 |
| 118 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.90727122 |
| 119 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.90276534 |
| 120 | positive regulation of interleukin-12 production (GO:0032735) | 2.89805232 |
| 121 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.89405278 |
| 122 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.89243798 |
| 123 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.88998241 |
| 124 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.88998241 |
| 125 | positive regulation of lymphocyte migration (GO:2000403) | 2.88213111 |
| 126 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87809067 |
| 127 | monocyte chemotaxis (GO:0002548) | 2.86727289 |
| 128 | fatty acid elongation (GO:0030497) | 2.85585421 |
| 129 | aromatic amino acid family catabolic process (GO:0009074) | 2.85428892 |
| 130 | type I interferon signaling pathway (GO:0060337) | 2.84659458 |
| 131 | cellular response to type I interferon (GO:0071357) | 2.84659458 |
| 132 | leukocyte degranulation (GO:0043299) | 2.84074797 |
| 133 | rRNA methylation (GO:0031167) | 2.84060617 |
| 134 | superoxide anion generation (GO:0042554) | 2.84041648 |
| 135 | protein deneddylation (GO:0000338) | 2.83128309 |
| 136 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.82958038 |
| 137 | positive regulation of ligase activity (GO:0051351) | 2.82604904 |
| 138 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.82164711 |
| 139 | regulation of cholesterol esterification (GO:0010872) | 2.81749748 |
| 140 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.81640571 |
| 141 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.81462333 |
| 142 | negative regulation of interleukin-17 production (GO:0032700) | 2.81212056 |
| 143 | S-adenosylmethionine metabolic process (GO:0046500) | 2.80436247 |
| 144 | amino acid salvage (GO:0043102) | 2.80063622 |
| 145 | L-methionine salvage (GO:0071267) | 2.80063622 |
| 146 | L-methionine biosynthetic process (GO:0071265) | 2.80063622 |
| 147 | natural killer cell activation involved in immune response (GO:0002323) | 2.80003500 |
| 148 | response to type I interferon (GO:0034340) | 2.78908079 |
| 149 | regulation of interferon-alpha production (GO:0032647) | 2.78091047 |
| 150 | NIK/NF-kappaB signaling (GO:0038061) | 2.77845216 |
| 151 | GPI anchor biosynthetic process (GO:0006506) | 2.77844447 |
| 152 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.77725647 |
| 153 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.77637635 |
| 154 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.77427895 |
| 155 | neutrophil mediated immunity (GO:0002446) | 2.76700531 |
| 156 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.76360463 |
| 157 | regulation of interleukin-17 production (GO:0032660) | 2.73852556 |
| 158 | myeloid dendritic cell differentiation (GO:0043011) | 2.73570655 |
| 159 | response to protozoan (GO:0001562) | 2.73395729 |
| 160 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.73064080 |
| 161 | myeloid dendritic cell activation (GO:0001773) | 2.71833388 |
| 162 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.71646806 |
| 163 | nucleoside salvage (GO:0043174) | 2.71612756 |
| 164 | translational elongation (GO:0006414) | 2.70507380 |
| 165 | detection of other organism (GO:0098543) | 2.70315701 |
| 166 | ATP biosynthetic process (GO:0006754) | 2.70060026 |
| 167 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.67961813 |
| 168 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.67073496 |
| 169 | signal peptide processing (GO:0006465) | 2.66810620 |
| 170 | T cell migration (GO:0072678) | 2.64345164 |
| 171 | regulation of T cell migration (GO:2000404) | 2.63336864 |
| 172 | regulation of T-helper 1 type immune response (GO:0002825) | 2.62689304 |
| 173 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.62095962 |
| 174 | macrophage activation involved in immune response (GO:0002281) | 2.61755835 |
| 175 | positive regulation of T cell migration (GO:2000406) | 2.59251494 |
| 176 | regulation of lymphocyte migration (GO:2000401) | 2.58545497 |
| 177 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.58171309 |
| 178 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.58033954 |
| 179 | reactive oxygen species biosynthetic process (GO:1903409) | 2.57584360 |
| 180 | detection of bacterium (GO:0016045) | 2.57356572 |
| 181 | positive regulation of defense response to virus by host (GO:0002230) | 2.57234786 |
| 182 | regulation of immunoglobulin secretion (GO:0051023) | 2.55180110 |
| 183 | positive regulation of type 2 immune response (GO:0002830) | 2.55048364 |
| 184 | aldehyde catabolic process (GO:0046185) | 2.54870556 |
| 185 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.54808663 |
| 186 | leukocyte mediated cytotoxicity (GO:0001909) | 2.51879002 |
| 187 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.51129721 |
| 188 | amyloid precursor protein metabolic process (GO:0042982) | 2.50521597 |
| 189 | GPI anchor metabolic process (GO:0006505) | 2.49507678 |
| 190 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.49350098 |
| 191 | positive regulation of humoral immune response (GO:0002922) | 2.49267605 |
| 192 | myeloid leukocyte activation (GO:0002274) | 2.46298545 |
| 193 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.46287312 |
| 194 | organelle membrane fusion (GO:0090174) | 2.45653314 |
| 195 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.44889584 |
| 196 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.44521889 |
| 197 | immunoglobulin mediated immune response (GO:0016064) | 2.43482027 |
| 198 | mast cell activation (GO:0045576) | 2.43263506 |
| 199 | regulation of T-helper cell differentiation (GO:0045622) | 2.41580031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.32908961 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.29652043 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 5.27340793 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.02291396 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.93214346 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.83366522 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.71420080 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.43964933 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.22650998 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.17189232 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.11115277 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.08291763 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.02265751 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.85258139 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.81734207 |
| 16 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.76309513 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75621169 |
| 18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.64354618 |
| 19 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.62687836 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.60573145 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.54383292 |
| 22 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.52887984 |
| 23 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.46087384 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.45783332 |
| 25 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.43846141 |
| 26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.34224536 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.32282741 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.31876884 |
| 29 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.28679766 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.27322316 |
| 31 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.24081389 |
| 32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.16612121 |
| 33 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.12926080 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09196600 |
| 35 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.04644519 |
| 36 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.02578068 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02500573 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.01527572 |
| 39 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00502682 |
| 40 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.00370290 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99647681 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.99629649 |
| 43 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.98250539 |
| 44 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.97991004 |
| 45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.97791825 |
| 46 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.92117372 |
| 47 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.91196276 |
| 48 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.87626468 |
| 49 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86230783 |
| 50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.71172587 |
| 51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.70664427 |
| 52 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70091881 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.69116557 |
| 54 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.68723660 |
| 55 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.67595197 |
| 56 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.65022989 |
| 57 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.62855504 |
| 58 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.61386196 |
| 59 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.60913954 |
| 60 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.55818432 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.52385509 |
| 62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.51756283 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48500292 |
| 64 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.48176776 |
| 65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47844071 |
| 66 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.45816324 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.45595654 |
| 68 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.44762253 |
| 69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44176279 |
| 70 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43267312 |
| 71 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.42787319 |
| 72 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.41015273 |
| 73 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.40237148 |
| 74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37829283 |
| 75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37527041 |
| 76 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.36531501 |
| 77 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34533541 |
| 78 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32949861 |
| 79 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.32807664 |
| 80 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30114371 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27036242 |
| 82 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.27003842 |
| 83 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26922684 |
| 84 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.26729472 |
| 85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25845342 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24061183 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21472470 |
| 88 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.21247736 |
| 89 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.21133510 |
| 90 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.20948005 |
| 91 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20239764 |
| 92 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19734249 |
| 93 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18909127 |
| 94 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.17451826 |
| 95 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.17239510 |
| 96 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.17207143 |
| 97 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16715155 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15594472 |
| 99 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.15197156 |
| 100 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.15080542 |
| 101 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.14882222 |
| 102 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14678883 |
| 103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14568645 |
| 104 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.14446200 |
| 105 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14410891 |
| 106 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14300390 |
| 107 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14291859 |
| 108 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14030303 |
| 109 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12997476 |
| 110 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12477010 |
| 111 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11916821 |
| 112 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11790880 |
| 113 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.11350531 |
| 114 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10198156 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09896565 |
| 116 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09792279 |
| 117 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09674517 |
| 118 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09230535 |
| 119 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.08997473 |
| 120 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08355433 |
| 121 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08190072 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08170113 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08170113 |
| 124 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08157865 |
| 125 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.08104441 |
| 126 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.07833423 |
| 127 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.07077698 |
| 128 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.06422477 |
| 129 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06039127 |
| 130 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05557844 |
| 131 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04622946 |
| 132 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.04612129 |
| 133 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03595597 |
| 134 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03426927 |
| 135 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.02124126 |
| 136 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01771269 |
| 137 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01433049 |
| 138 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.00570590 |
| 139 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99533305 |
| 140 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98724676 |
| 141 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.98625185 |
| 142 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.97729741 |
| 143 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97634915 |
| 144 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.95776763 |
| 145 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95654618 |
| 146 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.95136117 |
| 147 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.95071660 |
| 148 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94915967 |
| 149 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.94399100 |
| 150 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94205679 |
| 151 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.93680618 |
| 152 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92349908 |
| 153 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91838675 |
| 154 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91242907 |
| 155 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.90551708 |
| 156 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89900946 |
| 157 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.89559742 |
| 158 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89039082 |
| 159 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86898551 |
| 160 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86844584 |
| 161 | AR_20517297_ChIP-Seq_VCAP_Human | 0.86782586 |
| 162 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.80164045 |
| 163 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.79423419 |
| 164 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.78967931 |
| 165 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.78967931 |
| 166 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77336566 |
| 167 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.77143166 |
| 168 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.76534916 |
| 169 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.75855610 |
| 170 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.75076546 |
| 171 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.74565321 |
| 172 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.72922771 |
| 173 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.69110560 |
| 174 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.66983090 |
| 175 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.66223008 |
| 176 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.65976642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.26868656 |
| 2 | MP0009785_altered_susceptibility_to | 3.52577525 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.47406029 |
| 4 | MP0006082_CNS_inflammation | 3.12745108 |
| 5 | MP0006036_abnormal_mitochondrial_physio | 3.01959806 |
| 6 | MP0003724_increased_susceptibility_to | 2.85544582 |
| 7 | MP0002419_abnormal_innate_immunity | 2.77182136 |
| 8 | MP0005671_abnormal_response_to | 2.75763263 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.72183135 |
| 10 | MP0003436_decreased_susceptibility_to | 2.71815205 |
| 11 | MP0005025_abnormal_response_to | 2.68880238 |
| 12 | MP0000685_abnormal_immune_system | 2.62429548 |
| 13 | MP0005387_immune_system_phenotype | 2.43580897 |
| 14 | MP0001790_abnormal_immune_system | 2.43580897 |
| 15 | MP0002723_abnormal_immune_serum | 2.28244792 |
| 16 | MP0001800_abnormal_humoral_immune | 2.22849436 |
| 17 | MP0005084_abnormal_gallbladder_morpholo | 2.20504331 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.16923291 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.15286653 |
| 20 | MP0003693_abnormal_embryo_hatching | 2.14714984 |
| 21 | MP0008058_abnormal_DNA_repair | 2.06473495 |
| 22 | MP0004381_abnormal_hair_follicle | 2.05858828 |
| 23 | MP0004957_abnormal_blastocyst_morpholog | 2.01552166 |
| 24 | MP0000920_abnormal_myelination | 1.91546127 |
| 25 | MP0001819_abnormal_immune_cell | 1.90266495 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.88691845 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.86641950 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.82916133 |
| 29 | MP0003186_abnormal_redox_activity | 1.80768812 |
| 30 | MP0005451_abnormal_body_composition | 1.79173502 |
| 31 | MP0003786_premature_aging | 1.74554777 |
| 32 | MP0001853_heart_inflammation | 1.72374895 |
| 33 | MP0006035_abnormal_mitochondrial_morpho | 1.71837976 |
| 34 | MP0009764_decreased_sensitivity_to | 1.71702487 |
| 35 | MP0002254_reproductive_system_inflammat | 1.71475473 |
| 36 | MP0010094_abnormal_chromosome_stability | 1.71433816 |
| 37 | MP0003252_abnormal_bile_duct | 1.71010422 |
| 38 | MP0003690_abnormal_glial_cell | 1.69799588 |
| 39 | MP0005075_abnormal_melanosome_morpholog | 1.67018334 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 1.62257329 |
| 41 | MP0001666_abnormal_nutrient_absorption | 1.62078131 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.60439422 |
| 43 | MP0003136_yellow_coat_color | 1.60262094 |
| 44 | MP0003195_calcinosis | 1.59714495 |
| 45 | MP0003111_abnormal_nucleus_morphology | 1.58647534 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.58506901 |
| 47 | MP0008469_abnormal_protein_level | 1.57767002 |
| 48 | MP0003718_maternal_effect | 1.53578222 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.51670730 |
| 50 | MP0008875_abnormal_xenobiotic_pharmacok | 1.51104914 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.49441841 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.49045607 |
| 53 | MP0002277_abnormal_respiratory_mucosa | 1.48637743 |
| 54 | MP0002405_respiratory_system_inflammati | 1.47788241 |
| 55 | MP0009840_abnormal_foam_cell | 1.47215312 |
| 56 | MP0005310_abnormal_salivary_gland | 1.43511674 |
| 57 | MP0004782_abnormal_surfactant_physiolog | 1.39081959 |
| 58 | MP0005379_endocrine/exocrine_gland_phen | 1.38590396 |
| 59 | MP0000716_abnormal_immune_system | 1.32789077 |
| 60 | MP0001764_abnormal_homeostasis | 1.32240320 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.31838846 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.30940763 |
| 63 | MP0002837_dystrophic_cardiac_calcinosis | 1.30857036 |
| 64 | MP0008007_abnormal_cellular_replicative | 1.29980778 |
| 65 | MP0005408_hypopigmentation | 1.29284951 |
| 66 | MP0003950_abnormal_plasma_membrane | 1.28281690 |
| 67 | MP0002006_tumorigenesis | 1.28247655 |
| 68 | MP0002163_abnormal_gland_morphology | 1.27003559 |
| 69 | MP0004510_myositis | 1.26106399 |
| 70 | MP0003183_abnormal_peptide_metabolism | 1.25669556 |
| 71 | MP0008260_abnormal_autophagy | 1.24024882 |
| 72 | MP0005174_abnormal_tail_pigmentation | 1.23483510 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 1.20737198 |
| 74 | MP0002160_abnormal_reproductive_system | 1.19531129 |
| 75 | MP0009697_abnormal_copulation | 1.19298116 |
| 76 | MP0000604_amyloidosis | 1.18832831 |
| 77 | MP0001986_abnormal_taste_sensitivity | 1.18686216 |
| 78 | MP0005670_abnormal_white_adipose | 1.18413682 |
| 79 | MP0003077_abnormal_cell_cycle | 1.17182506 |
| 80 | MP0005646_abnormal_pituitary_gland | 1.14530422 |
| 81 | MP0008877_abnormal_DNA_methylation | 1.13221010 |
| 82 | MP0003011_delayed_dark_adaptation | 1.11519810 |
| 83 | MP0001851_eye_inflammation | 1.11296673 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 1.11116019 |
| 85 | MP0009379_abnormal_foot_pigmentation | 1.10785008 |
| 86 | MP0001905_abnormal_dopamine_level | 1.10521995 |
| 87 | MP0002166_altered_tumor_susceptibility | 1.10107933 |
| 88 | MP0000609_abnormal_liver_physiology | 1.09281699 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 1.09219648 |
| 90 | MP0010155_abnormal_intestine_physiology | 1.08277361 |
| 91 | MP0002398_abnormal_bone_marrow | 1.07282688 |
| 92 | MP0009763_increased_sensitivity_to | 1.06867022 |
| 93 | MP0004947_skin_inflammation | 1.06815944 |
| 94 | MP0002876_abnormal_thyroid_physiology | 1.06242516 |
| 95 | MP0008872_abnormal_physiological_respon | 1.04770328 |
| 96 | MP0005389_reproductive_system_phenotype | 1.04448349 |
| 97 | MP0005085_abnormal_gallbladder_physiolo | 1.04064999 |
| 98 | MP0005410_abnormal_fertilization | 1.03982566 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 1.02702700 |
| 100 | MP0004147_increased_porphyrin_level | 1.01112419 |
| 101 | MP0003075_altered_response_to | 0.99760154 |
| 102 | MP0000015_abnormal_ear_pigmentation | 0.99108965 |
| 103 | MP0002429_abnormal_blood_cell | 0.98943360 |
| 104 | MP0000689_abnormal_spleen_morphology | 0.98921581 |
| 105 | MP0009643_abnormal_urine_homeostasis | 0.97613535 |
| 106 | MP0008873_increased_physiological_sensi | 0.95486975 |
| 107 | MP0002938_white_spotting | 0.95011918 |
| 108 | MP0001881_abnormal_mammary_gland | 0.94145456 |
| 109 | MP0002102_abnormal_ear_morphology | 0.93648940 |
| 110 | MP0000372_irregular_coat_pigmentation | 0.92705989 |
| 111 | MP0005360_urolithiasis | 0.92658190 |
| 112 | MP0005645_abnormal_hypothalamus_physiol | 0.92363880 |
| 113 | MP0002118_abnormal_lipid_homeostasis | 0.90412202 |
| 114 | MP0003941_abnormal_skin_development | 0.89774975 |
| 115 | MP0003123_paternal_imprinting | 0.89088539 |
| 116 | MP0002132_abnormal_respiratory_system | 0.88853786 |
| 117 | MP0002090_abnormal_vision | 0.87823301 |
| 118 | MP0006072_abnormal_retinal_apoptosis | 0.87683294 |
| 119 | MP0005365_abnormal_bile_salt | 0.86881866 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.86709311 |
| 121 | MP0002396_abnormal_hematopoietic_system | 0.85798347 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84657758 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.83178952 |
| 124 | MP0005171_absent_coat_pigmentation | 0.82056362 |
| 125 | MP0002722_abnormal_immune_system | 0.82025009 |
| 126 | MP0005266_abnormal_metabolism | 0.82019124 |
| 127 | MP0005164_abnormal_response_to | 0.81896711 |
| 128 | MP0009642_abnormal_blood_homeostasis | 0.81433529 |
| 129 | MP0001346_abnormal_lacrimal_gland | 0.81224993 |
| 130 | MP0003868_abnormal_feces_composition | 0.80961629 |
| 131 | MP0005376_homeostasis/metabolism_phenot | 0.80533256 |
| 132 | MP0008932_abnormal_embryonic_tissue | 0.79989290 |
| 133 | MP0000343_altered_response_to | 0.79414572 |
| 134 | MP0001529_abnormal_vocalization | 0.78992278 |
| 135 | MP0010386_abnormal_urinary_bladder | 0.78755926 |
| 136 | MP0008004_abnormal_stomach_pH | 0.77664397 |
| 137 | MP0004142_abnormal_muscle_tone | 0.77108465 |
| 138 | MP0002638_abnormal_pupillary_reflex | 0.76788685 |
| 139 | MP0000465_gastrointestinal_hemorrhage | 0.75079797 |
| 140 | MP0006292_abnormal_olfactory_placode | 0.74174821 |
| 141 | MP0001919_abnormal_reproductive_system | 0.73495764 |
| 142 | MP0003763_abnormal_thymus_physiology | 0.72392672 |
| 143 | MP0005332_abnormal_amino_acid | 0.72121983 |
| 144 | MP0005551_abnormal_eye_electrophysiolog | 0.71336563 |
| 145 | MP0000598_abnormal_liver_morphology | 0.71145706 |
| 146 | MP0002998_abnormal_bone_remodeling | 0.70832058 |
| 147 | MP0001661_extended_life_span | 0.70410936 |
| 148 | MP0005395_other_phenotype | 0.69547370 |
| 149 | MP0003638_abnormal_response/metabolism_ | 0.69171485 |
| 150 | MP0008057_abnormal_DNA_replication | 0.68803507 |
| 151 | MP0005409_darkened_coat_color | 0.68157176 |
| 152 | MP0002736_abnormal_nociception_after | 0.67812856 |
| 153 | MP0005083_abnormal_biliary_tract | 0.67311387 |
| 154 | MP0003448_altered_tumor_morphology | 0.66966917 |
| 155 | MP0004742_abnormal_vestibular_system | 0.66912817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.92734887 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.81370097 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.86175259 |
| 4 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.79091029 |
| 5 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.79091029 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.73547011 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.68948568 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.62023419 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 3.59798815 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 3.57916080 |
| 11 | Stomatitis (HP:0010280) | 3.54608959 |
| 12 | Recurrent skin infections (HP:0001581) | 3.36100153 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.20946654 |
| 14 | Hyperglycinemia (HP:0002154) | 3.13530663 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 3.13068058 |
| 16 | Increased serum lactate (HP:0002151) | 3.12077461 |
| 17 | Lactic acidosis (HP:0003128) | 3.10846940 |
| 18 | Renal Fanconi syndrome (HP:0001994) | 3.09778803 |
| 19 | Parakeratosis (HP:0001036) | 3.07807217 |
| 20 | Glycosuria (HP:0003076) | 3.02875294 |
| 21 | Abnormality of urine glucose concentration (HP:0011016) | 3.02875294 |
| 22 | Optic neuritis (HP:0100653) | 3.01999395 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.01999395 |
| 24 | Abnormality of serum amino acid levels (HP:0003112) | 2.96562712 |
| 25 | Increased intramyocellular lipid droplets (HP:0012240) | 2.95579415 |
| 26 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.93232027 |
| 27 | Increased serum pyruvate (HP:0003542) | 2.90148093 |
| 28 | Lethargy (HP:0001254) | 2.89681453 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.85395474 |
| 30 | Prolonged partial thromboplastin time (HP:0003645) | 2.82372987 |
| 31 | Respiratory failure (HP:0002878) | 2.79867732 |
| 32 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.79847306 |
| 33 | Hyperalaninemia (HP:0003348) | 2.79360212 |
| 34 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.79360212 |
| 35 | Abnormality of alanine metabolism (HP:0010916) | 2.79360212 |
| 36 | Axonal loss (HP:0003447) | 2.76654060 |
| 37 | Myositis (HP:0100614) | 2.74706070 |
| 38 | Macrocytic anemia (HP:0001972) | 2.73047444 |
| 39 | Methylmalonic aciduria (HP:0012120) | 2.68378250 |
| 40 | Vasculitis (HP:0002633) | 2.67796797 |
| 41 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61677362 |
| 42 | Systemic lupus erythematosus (HP:0002725) | 2.61147128 |
| 43 | Hepatosplenomegaly (HP:0001433) | 2.60336590 |
| 44 | Nausea (HP:0002018) | 2.58194890 |
| 45 | Joint hemorrhage (HP:0005261) | 2.58113018 |
| 46 | Hypothermia (HP:0002045) | 2.57494736 |
| 47 | Increased muscle lipid content (HP:0009058) | 2.56085142 |
| 48 | Aplastic anemia (HP:0001915) | 2.55549053 |
| 49 | Orchitis (HP:0100796) | 2.55348126 |
| 50 | Exercise intolerance (HP:0003546) | 2.54513393 |
| 51 | Amyloidosis (HP:0011034) | 2.51624267 |
| 52 | Abnormality of glycolysis (HP:0004366) | 2.46604747 |
| 53 | Gingivitis (HP:0000230) | 2.43669156 |
| 54 | Obstructive lung disease (HP:0006536) | 2.43653534 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.43653534 |
| 56 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.42410377 |
| 57 | Hypoglycemic coma (HP:0001325) | 2.41690773 |
| 58 | 3-Methylglutaconic aciduria (HP:0003535) | 2.40922898 |
| 59 | Increased IgM level (HP:0003496) | 2.39819759 |
| 60 | Prolonged neonatal jaundice (HP:0006579) | 2.39522006 |
| 61 | Exertional dyspnea (HP:0002875) | 2.39405800 |
| 62 | Prostate neoplasm (HP:0100787) | 2.37821159 |
| 63 | Increased hepatocellular lipid droplets (HP:0006565) | 2.37615050 |
| 64 | Recurrent fungal infections (HP:0002841) | 2.37393755 |
| 65 | Respiratory difficulties (HP:0002880) | 2.37073182 |
| 66 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.37004672 |
| 67 | Hyperphosphaturia (HP:0003109) | 2.35729008 |
| 68 | Acute necrotizing encephalopathy (HP:0006965) | 2.30902121 |
| 69 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.29725072 |
| 70 | Dicarboxylic aciduria (HP:0003215) | 2.29725072 |
| 71 | Patchy hypopigmentation of hair (HP:0011365) | 2.26046894 |
| 72 | Abnormal number of erythroid precursors (HP:0012131) | 2.25273393 |
| 73 | Spontaneous abortion (HP:0005268) | 2.24318110 |
| 74 | Microvesicular hepatic steatosis (HP:0001414) | 2.22394790 |
| 75 | Gout (HP:0001997) | 2.22277491 |
| 76 | Mitochondrial inheritance (HP:0001427) | 2.20440695 |
| 77 | Basal ganglia calcification (HP:0002135) | 2.20263552 |
| 78 | Abnormal protein glycosylation (HP:0012346) | 2.19177052 |
| 79 | Abnormal glycosylation (HP:0012345) | 2.19177052 |
| 80 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.19177052 |
| 81 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.19177052 |
| 82 | Lipid accumulation in hepatocytes (HP:0006561) | 2.18819088 |
| 83 | CNS demyelination (HP:0007305) | 2.18550730 |
| 84 | Periodontitis (HP:0000704) | 2.17608609 |
| 85 | White forelock (HP:0002211) | 2.17172787 |
| 86 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.17029033 |
| 87 | Optic disc pallor (HP:0000543) | 2.16114844 |
| 88 | Recurrent pneumonia (HP:0006532) | 2.15497796 |
| 89 | Abnormality of renal resorption (HP:0011038) | 2.14067854 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 2.13168083 |
| 91 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.13168083 |
| 92 | Autoimmune thrombocytopenia (HP:0001973) | 2.10565970 |
| 93 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.09389729 |
| 94 | Gingival bleeding (HP:0000225) | 2.08506962 |
| 95 | Abnormality of vitamin B metabolism (HP:0004340) | 2.08439748 |
| 96 | Microretrognathia (HP:0000308) | 2.07107066 |
| 97 | Type I transferrin isoform profile (HP:0003642) | 2.06789457 |
| 98 | Pancytopenia (HP:0001876) | 2.05952024 |
| 99 | Testicular atrophy (HP:0000029) | 2.05309555 |
| 100 | Metabolic acidosis (HP:0001942) | 2.04228017 |
| 101 | Meningitis (HP:0001287) | 2.03979233 |
| 102 | Abnormality of the anterior horn cell (HP:0006802) | 2.03837420 |
| 103 | Degeneration of anterior horn cells (HP:0002398) | 2.03837420 |
| 104 | Megaloblastic anemia (HP:0001889) | 2.02682855 |
| 105 | Acute encephalopathy (HP:0006846) | 2.02369523 |
| 106 | Neurofibrillary tangles (HP:0002185) | 2.01727451 |
| 107 | Hyperammonemia (HP:0001987) | 2.00599842 |
| 108 | Purpura (HP:0000979) | 2.00244016 |
| 109 | Increased cerebral lipofuscin (HP:0011813) | 1.98938404 |
| 110 | Urticaria (HP:0001025) | 1.98750549 |
| 111 | Abnormality of glycine metabolism (HP:0010895) | 1.98617777 |
| 112 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.98617777 |
| 113 | Cleft eyelid (HP:0000625) | 1.97972704 |
| 114 | Recurrent viral infections (HP:0004429) | 1.96709650 |
| 115 | Hypolipoproteinemia (HP:0010981) | 1.96344108 |
| 116 | Leukocytosis (HP:0001974) | 1.96183249 |
| 117 | Symptomatic seizures (HP:0011145) | 1.95292626 |
| 118 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.95209553 |
| 119 | Hypoglycemic seizures (HP:0002173) | 1.94798397 |
| 120 | Hepatocellular necrosis (HP:0001404) | 1.94700878 |
| 121 | Abnormality of the prostate (HP:0008775) | 1.94148928 |
| 122 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.93148966 |
| 123 | Pulmonary infiltrates (HP:0002113) | 1.91561887 |
| 124 | Joint swelling (HP:0001386) | 1.90388539 |
| 125 | Gastrointestinal infarctions (HP:0005244) | 1.89802194 |
| 126 | Thick nail (HP:0001805) | 1.89456819 |
| 127 | Oral leukoplakia (HP:0002745) | 1.89277253 |
| 128 | Methylmalonic acidemia (HP:0002912) | 1.88537127 |
| 129 | Hyperlipoproteinemia (HP:0010980) | 1.87809901 |
| 130 | Epistaxis (HP:0000421) | 1.87416478 |
| 131 | Hepatic necrosis (HP:0002605) | 1.87323713 |
| 132 | Abnormality of vitamin metabolism (HP:0100508) | 1.87125823 |
| 133 | Vomiting (HP:0002013) | 1.86490676 |
| 134 | X-linked dominant inheritance (HP:0001423) | 1.86306556 |
| 135 | Keratoconjunctivitis (HP:0001096) | 1.86287841 |
| 136 | Multiple enchondromatosis (HP:0005701) | 1.85982501 |
| 137 | Neutropenia (HP:0001875) | 1.85385448 |
| 138 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.85085540 |
| 139 | Hypomagnesemia (HP:0002917) | 1.84248655 |
| 140 | Keratoconjunctivitis sicca (HP:0001097) | 1.83809857 |
| 141 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.83268598 |
| 142 | Progressive macrocephaly (HP:0004481) | 1.83169582 |
| 143 | Eosinophilia (HP:0001880) | 1.82836124 |
| 144 | Reduced antithrombin III activity (HP:0001976) | 1.82043275 |
| 145 | Gangrene (HP:0100758) | 1.81002174 |
| 146 | Cerebral hemorrhage (HP:0001342) | 1.80853068 |
| 147 | Ketosis (HP:0001946) | 1.79069800 |
| 148 | Intrahepatic cholestasis (HP:0001406) | 1.79055380 |
| 149 | Chronic otitis media (HP:0000389) | 1.78655367 |
| 150 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.78249483 |
| 151 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.77786217 |
| 152 | Palpitations (HP:0001962) | 1.77021790 |
| 153 | Dry hair (HP:0011359) | 1.76919139 |
| 154 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.76813429 |
| 155 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.76642283 |
| 156 | Glomerulonephritis (HP:0000099) | 1.76403097 |
| 157 | Steatorrhea (HP:0002570) | 1.75713887 |
| 158 | Hemoptysis (HP:0002105) | 1.75301576 |
| 159 | Hypergammaglobulinemia (HP:0010702) | 1.75132117 |
| 160 | Cerebral edema (HP:0002181) | 1.74049689 |
| 161 | Abnormality of eosinophils (HP:0001879) | 1.73644930 |
| 162 | Granulocytopenia (HP:0001913) | 1.73296226 |
| 163 | Pustule (HP:0200039) | 1.72949013 |
| 164 | Pallor (HP:0000980) | 1.72742077 |
| 165 | Erythroderma (HP:0001019) | 1.72270670 |
| 166 | Leukodystrophy (HP:0002415) | 1.71945832 |
| 167 | Increased CSF lactate (HP:0002490) | 1.71582810 |
| 168 | Abnormal hair whorl (HP:0010721) | 1.71288591 |
| 169 | Generalized aminoaciduria (HP:0002909) | 1.71254644 |
| 170 | Autoimmune hemolytic anemia (HP:0001890) | 1.71082382 |
| 171 | Petechiae (HP:0000967) | 1.70925599 |
| 172 | Poor head control (HP:0002421) | 1.70478735 |
| 173 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.68645261 |
| 174 | Abnormality of glycolipid metabolism (HP:0010969) | 1.68645261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.26929225 |
| 2 | MAP3K14 | 3.83230507 |
| 3 | BLK | 3.12339198 |
| 4 | PBK | 3.06169295 |
| 5 | IRAK4 | 3.00836999 |
| 6 | RIPK4 | 2.89151017 |
| 7 | IRAK3 | 2.83713678 |
| 8 | VRK2 | 2.81804689 |
| 9 | EIF2AK1 | 2.73828669 |
| 10 | PDK2 | 2.61809891 |
| 11 | ZAK | 2.31182347 |
| 12 | IKBKE | 2.19037418 |
| 13 | TXK | 2.19020293 |
| 14 | TBK1 | 2.18660058 |
| 15 | NEK1 | 2.11661703 |
| 16 | IKBKB | 2.08955913 |
| 17 | BMPR2 | 2.08015336 |
| 18 | TNIK | 2.03992853 |
| 19 | TYK2 | 2.03688250 |
| 20 | CDC7 | 1.96489779 |
| 21 | BMPR1B | 1.96356282 |
| 22 | KIT | 1.92259127 |
| 23 | NME2 | 1.84389867 |
| 24 | STK16 | 1.79606332 |
| 25 | PIK3CG | 1.69560012 |
| 26 | MST4 | 1.69378948 |
| 27 | NME1 | 1.69299540 |
| 28 | MUSK | 1.57578153 |
| 29 | JAK3 | 1.55350235 |
| 30 | MAP3K13 | 1.51375576 |
| 31 | MAP4K2 | 1.50467168 |
| 32 | MAPKAPK5 | 1.50274997 |
| 33 | SCYL2 | 1.45695165 |
| 34 | PKN1 | 1.45659482 |
| 35 | GRK7 | 1.44963716 |
| 36 | TAOK3 | 1.44956341 |
| 37 | ADRBK2 | 1.42648226 |
| 38 | PLK3 | 1.41170580 |
| 39 | MAP4K1 | 1.40758758 |
| 40 | MAPK15 | 1.37099784 |
| 41 | BTK | 1.31538255 |
| 42 | TRIM28 | 1.29503740 |
| 43 | TEC | 1.29497054 |
| 44 | TTK | 1.29444070 |
| 45 | FRK | 1.27796250 |
| 46 | SYK | 1.25688588 |
| 47 | WNK3 | 1.23406543 |
| 48 | SRPK1 | 1.22791413 |
| 49 | EIF2AK2 | 1.20316351 |
| 50 | PIM2 | 1.16277296 |
| 51 | CSF1R | 1.15836566 |
| 52 | STK39 | 1.14725340 |
| 53 | MAP3K12 | 1.14276238 |
| 54 | EPHB1 | 1.14170255 |
| 55 | LYN | 1.08301046 |
| 56 | OXSR1 | 1.08066145 |
| 57 | VRK1 | 1.07416400 |
| 58 | TESK1 | 1.07097596 |
| 59 | CLK1 | 1.06896732 |
| 60 | CHUK | 1.05942136 |
| 61 | FGR | 1.04938898 |
| 62 | YES1 | 1.04143704 |
| 63 | PLK1 | 1.01222484 |
| 64 | JAK1 | 0.98908661 |
| 65 | BCR | 0.98393619 |
| 66 | CASK | 0.98240649 |
| 67 | IRAK1 | 0.97794606 |
| 68 | LCK | 0.96719884 |
| 69 | TRPM7 | 0.93064136 |
| 70 | DAPK1 | 0.91898205 |
| 71 | ZAP70 | 0.89992415 |
| 72 | KDR | 0.88751579 |
| 73 | NLK | 0.88658622 |
| 74 | BRSK2 | 0.80587755 |
| 75 | NEK6 | 0.78418694 |
| 76 | RPS6KA5 | 0.77839757 |
| 77 | CDK19 | 0.77196567 |
| 78 | WEE1 | 0.76746340 |
| 79 | ARAF | 0.76087914 |
| 80 | ABL2 | 0.75257037 |
| 81 | ITK | 0.74165313 |
| 82 | CSNK2A2 | 0.74123526 |
| 83 | ILK | 0.74062980 |
| 84 | CSNK2A1 | 0.73669343 |
| 85 | TGFBR2 | 0.71959145 |
| 86 | INSRR | 0.71721759 |
| 87 | TSSK6 | 0.71602050 |
| 88 | CSK | 0.70324507 |
| 89 | PASK | 0.68922226 |
| 90 | FES | 0.67772446 |
| 91 | IRAK2 | 0.67035221 |
| 92 | AURKB | 0.64627391 |
| 93 | PRKCQ | 0.64457507 |
| 94 | TESK2 | 0.64415524 |
| 95 | STK10 | 0.61990766 |
| 96 | TNK2 | 0.61956046 |
| 97 | DYRK3 | 0.61922977 |
| 98 | PRPF4B | 0.61178729 |
| 99 | DYRK2 | 0.61078491 |
| 100 | PRKCD | 0.60977974 |
| 101 | MAP3K11 | 0.60142615 |
| 102 | MAP2K6 | 0.59930363 |
| 103 | MAP3K6 | 0.59910618 |
| 104 | HCK | 0.59065214 |
| 105 | MYLK | 0.56132511 |
| 106 | MAP3K3 | 0.55716187 |
| 107 | PIM1 | 0.55661600 |
| 108 | NEK9 | 0.55160060 |
| 109 | GRK6 | 0.54997933 |
| 110 | PRKCI | 0.54951117 |
| 111 | MATK | 0.54670183 |
| 112 | SIK3 | 0.53256412 |
| 113 | PLK4 | 0.53234730 |
| 114 | LRRK2 | 0.51423477 |
| 115 | MKNK2 | 0.50838936 |
| 116 | BCKDK | 0.50096354 |
| 117 | NUAK1 | 0.49740775 |
| 118 | PRKG2 | 0.48704065 |
| 119 | EIF2AK3 | 0.47813600 |
| 120 | MOS | 0.47071780 |
| 121 | PRKCE | 0.47015910 |
| 122 | ATR | 0.46471060 |
| 123 | JAK2 | 0.46440246 |
| 124 | ERBB4 | 0.45960830 |
| 125 | TAOK2 | 0.44558500 |
| 126 | TAF1 | 0.44539086 |
| 127 | RPS6KA4 | 0.44162899 |
| 128 | TLK1 | 0.44004996 |
| 129 | CSNK1G3 | 0.43556523 |
| 130 | TAOK1 | 0.43331146 |
| 131 | EPHA3 | 0.42568286 |
| 132 | CSNK1G1 | 0.42098324 |
| 133 | ALK | 0.41195456 |
| 134 | FGFR4 | 0.40722592 |
| 135 | ABL1 | 0.39741427 |
| 136 | GRK5 | 0.39386259 |
| 137 | MKNK1 | 0.39095284 |
| 138 | AURKA | 0.38808518 |
| 139 | ACVR1B | 0.37535765 |
| 140 | MAP2K3 | 0.37006655 |
| 141 | MAP3K5 | 0.36477809 |
| 142 | CHEK2 | 0.36070545 |
| 143 | GRK1 | 0.34998407 |
| 144 | STK4 | 0.34598613 |
| 145 | CDK3 | 0.33850140 |
| 146 | PAK1 | 0.33145084 |
| 147 | CSNK1A1L | 0.31973445 |
| 148 | FLT3 | 0.31496812 |
| 149 | CAMK2G | 0.31103575 |
| 150 | ADRBK1 | 0.30435506 |
| 151 | MAPK4 | 0.30121109 |
| 152 | PIK3CA | 0.29903060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.90854268 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 2.85388795 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.65697843 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.50837348 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.24114690 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.16862530 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.06113006 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.05250678 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.03163063 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.97969988 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.94725466 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.94491328 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 1.94319391 |
| 14 | * One carbon pool by folate_Homo sapiens_hsa00670 | 1.93666441 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.93651266 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.92223571 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91391961 |
| 18 | DNA replication_Homo sapiens_hsa03030 | 1.89420714 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.83587467 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.83169887 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.76997721 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75405157 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.71530719 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.70485162 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67356499 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.65281927 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64858682 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.63230533 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.60164014 |
| 30 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.57483741 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.56909363 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.53649991 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.51532786 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.46792326 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.44668314 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41235254 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41102086 |
| 38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.39484817 |
| 39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.39001286 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.37531659 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.36418196 |
| 42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.33695582 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33015604 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32497636 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.32235502 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30632634 |
| 47 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.30251173 |
| 48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.29309510 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.28000639 |
| 50 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.26446172 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.25984786 |
| 52 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25535683 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.25351916 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.24183733 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.23925774 |
| 56 | Measles_Homo sapiens_hsa05162 | 1.23761399 |
| 57 | Peroxisome_Homo sapiens_hsa04146 | 1.23703575 |
| 58 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21120426 |
| 59 | Base excision repair_Homo sapiens_hsa03410 | 1.20407325 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.20341348 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.17840802 |
| 62 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15241370 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 1.14914462 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.14819899 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14703802 |
| 66 | Ribosome_Homo sapiens_hsa03010 | 1.13718336 |
| 67 | Proteasome_Homo sapiens_hsa03050 | 1.12320590 |
| 68 | Spliceosome_Homo sapiens_hsa03040 | 1.08110711 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.08001614 |
| 70 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07540989 |
| 71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07416331 |
| 72 | RNA degradation_Homo sapiens_hsa03018 | 1.06456511 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 1.04846491 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 1.04091654 |
| 75 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.03063138 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 1.01306577 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00876806 |
| 78 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.98764854 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98154313 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.98015047 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95828272 |
| 82 | RNA transport_Homo sapiens_hsa03013 | 0.94973929 |
| 83 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93286962 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88725366 |
| 85 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.88161088 |
| 86 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87777434 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.83622211 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.83355867 |
| 89 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83259347 |
| 90 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.81894713 |
| 91 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81574305 |
| 92 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81438955 |
| 93 | Basal transcription factors_Homo sapiens_hsa03022 | 0.79975092 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.79600390 |
| 95 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.79258976 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78143392 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78096227 |
| 98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78052680 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77218356 |
| 100 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76068825 |
| 101 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75454807 |
| 102 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74640638 |
| 103 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.74300084 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73865056 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72476718 |
| 106 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72137207 |
| 107 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70904696 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69812260 |
| 109 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69577783 |
| 110 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68436980 |
| 111 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.68299886 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.66878087 |
| 113 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66256103 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.62900432 |
| 115 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61322098 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61028450 |
| 117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59391913 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57931312 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57768694 |
| 120 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57527773 |
| 121 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55091380 |
| 122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54878543 |
| 123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.54858324 |
| 124 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.52833234 |
| 125 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51879810 |
| 126 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50590628 |
| 127 | Hepatitis C_Homo sapiens_hsa05160 | 0.49467548 |
| 128 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47945745 |
| 129 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47692810 |
| 130 | RNA polymerase_Homo sapiens_hsa03020 | 0.47358100 |
| 131 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46381886 |
| 132 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45851588 |
| 133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45052663 |
| 134 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42936334 |
| 135 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39556017 |
| 136 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38975289 |
| 137 | Apoptosis_Homo sapiens_hsa04210 | 0.38915159 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37738770 |
| 139 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37589174 |
| 140 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.32243350 |
| 141 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.31431139 |
| 142 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27075135 |
| 143 | Mineral absorption_Homo sapiens_hsa04978 | 0.24620053 |

